Stability of pantoprazole in an extemporaneously compounded oral liquid.
Dentinger
Paul J
PJ
Department of Pharmacy, Strong Memorial Hospital, Rochester, NY, USA.
Swenson
Chad F
CF
Anaizi
Nasr H
NH
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000284:Administration, Oral; D000897:Anti-Ulcer Agents / Q000008:administration & dosage / Q000737:chemistry*; D001562:Benzimidazoles / Q000008:administration & dosage / Q000737:chemistry*; D002851:Chromatography, High Pressure Liquid; D004339:Drug Compounding; D004355:Drug Stability; D004356:Drug Storage; D006863:Hydrogen-Ion Concentration; D009853:Omeprazole / Q000031:analogs & derivatives; D000077402:Pantoprazole; D017693:Sodium Bicarbonate; D013454:Sulfoxides / Q000008:administration & dosage / Q000737:chemistry*; D013535:Suspensions; D013607:Tablets; D014867:Water
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000897:Anti-Ulcer Agents; D001562:Benzimidazoles; D013454:Sulfoxides; D013535:Suspensions; D013607:Tablets; D014867:Water; D017693:Sodium Bicarbonate; D000077402:Pantoprazole; D009853:Omeprazole